Newborn screening for pompe disease in Illinois: Experience with 684,290 infants

  • Barbara K. Burton
  • , Joel Charrow
  • , George E. Hoganson
  • , Julie Fleischer
  • , Dorothy K. Grange
  • , Stephen R. Braddock
  • , Lauren Hitchins
  • , Rachel Hickey
  • , Katherine M. Christensen
  • , Daniel Groepper
  • , Heather Shryock
  • , Pamela Smith
  • , Rong Shao
  • , Khaja Basheeruddin

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

Statewide newborn screening for Pompe disease began in Illinois in 2015. As of 30 September 2019, a total of 684,290 infants had been screened and 395 infants (0.06%) were screen positive. A total of 29 cases of Pompe disease were identified (3 infantile, 26 late-onset). While many of the remainder were found to have normal alpha-glucosidase activity on the follow-up testing (234 of 395), other findings included 62 carriers, 39 infants with pseudodeficiency, and eight infants who could not be given a definitive diagnosis due to inconclusive follow-up testing.

Original languageEnglish
Article number285
JournalInternational Journal of Neonatal Screening
Volume6
Issue number1
DOIs
StatePublished - 2020

Keywords

  • Newborn screening
  • Pompe disease

Fingerprint

Dive into the research topics of 'Newborn screening for pompe disease in Illinois: Experience with 684,290 infants'. Together they form a unique fingerprint.

Cite this